Healthscope: Near-term uncertain, but drivers intact

Increased 1Q variability in Hospital volumes/case mix has seen HSO warn of soft divisional revenue growth and flat divisional growth if the trend continues through FY17. Negative publicity around affordability and consumer confidence were cited as the main cause of weakness, with October looking likely to improve and no fundamental change in industry dynamics. While noting some ambiguity, along with the need for further case-mix optimisation, makes the near-term outlook uncertain and will likely take time for shares to recover, we continue to view core industry drivers as intact, brownfields on track, capital structure secure and contract pricing stable.


1 stock mentioned

Scott Power
Senior Analyst
Morgans

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.